BEACOLYTIC TABLET 8MG

Страна: Малайзия

Език: английски

Източник: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Активна съставка:

Bromhexine HCl

Предлага се от:

DUOPHARMA MANUFACTURING (BANGI) SDN BHD

INN (Международно Name):

Bromhexine HCl

Броя в опаковка:

30Tablet Tablets; 12x30`s Tablets

Произведено от:

DUOPHARMA MANUFACTURING (BANGI) SDN BHD

Листовка

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
1
BEACOLYTIC ELIXIR/TABLET
Bromhexine hydrochloride (4mg/5ml , 8mg)
WHAT IS IN THE LEAFLET
1.
What Beacolytic is used for
2.
How Beacolytic works
3.
Before you use Beacolytic
4.
How to use Beacolytic
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
Beacolytic
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
WHAT BEACOLYTIC IS USED FOR
Beacolytic
is
used
to
reduce
phlegm
thickness,
thus
facilitate
its
removal
by
coughing.
HOW BEACOLYTIC WORKS
Beacolytic
contains
bromhexine
hydrochloride
as
an
active
ingredient.
Bromhexine
hydrochloride
helps
to
clear
the
chest
by
thinning the phlegm in your air
passages.
BEFORE YOU USE BEACOLYTIC
-
_When you must not take it _
Do not take this medicine if
you have an allergy to:

Bromhexine hydrochloride

any of the other ingredients
listed
at
the
end
of
this
leaflet
Do not take this medicine after
the expiry date printed on the
pack or if the packaging is torn
or shows signs of tampering.
If it has expired or is damaged,
return it to your pharmacist for
disposal.
If you are not sure whether you
should
start
taking
this
medicine, talk to your doctor.
-
_Before you start to use it _
Tell your doctor if you have
-
allergies
to
any
other
medicines,
foods,
preservatives or dyes
- gastric ulcer.
Ask your doctor or pharmacist
for
advice
before
taking
this
medicine if you are pregnant or
breastfeeding.
-
_Taking other medicines _
Tell your doctor or pharmacist
if
you
are
taking
any
other
medicines, including any that
you get without a prescription
from
your
pharmacy,
supermarket
or
health
food
shop.
Some
medicines
and
Beacolytic may interfere with
each other.
You
may
need
different
amounts of your medicines, or
you may need to take different
medicines.
Your
doctor
and
pharmacist
have
more
information
on
medicines to be careful with or
avoid
while
taking
this
medicine.
HOW TO USE BEACOLYTIC
Follow all directions given to
you
by
your
doctor
and
pharmacist carefully.
These

Данни за продукта

PRODUCT INFORMATION
BEACOLYTIC TABLET/ELIXIR
BEACOLYTIC contains Bromhexine HCI. It is a
mucolytic
agent
facilitating
expectoration
by
reducing
sputum
viscosity
and
relieving
wet
cough.
PRODUCT DESCRIPTION
TABLET: A 7 mm in diameter, round, flat, plain
yellow tablet.
ELIXIR: A plain, strawberry flavoured syrup.
PHARMACODYNAMICS
Bromhexine HCl can facilitate expectoration
by
reducing sputum viscosity in chronic asthma and
bronchitis.
PHARMACOKINETICS
Bromhexine HCl is absorbed from the G.I.T and
peak plasma concentrations occurs after 1 hour.
Most of the dose is excreted in the urine mainly as
metabolites.
INDICATION
Reduction in sputum viscosity, thus facilitate its
removal by coughing.
DOSAGE
Adults and children above 12 years: 1 to 2
tablets three times daily or 10ml three times daily
OR as directed by physician.
Children
under
6
years:
5
ml
twice
d a i l y .
Children
6
to
12
years:
5ml
three
t i m e s
daily OR as directed by physician.
It‘s advisable to drink more warm water.
ADVERSE EFFECTS/UNDESIRABLE
EFFECTS:
Gastrointestinal
irritation,
transient
increased
serum transaminase.
Immune System Disorders
Frequency not known: Anaphylactic reactions
including anaphylactic shock.
Skin
and
Subcutaneous
Skin
Disorders
Frequency not known: Severe skin reactions
(including
Stevens
Johnson
syndrome,
Toxic
epidermal
necrolysis
(TEN),
Erythema
Multiforme
(EM)
and
Acute
Generalized
Exanthematous Pustulosis (AGEP).
WARNINGS AND PRECAUTIONS:
Gastric Ulceration. Very rare cases of chronically
associated
severe
skin
impairments
such
as
Stevens Johnson Syndrome, Toxic Epidermal
Necrolysis (TEN), Erytheme Multiforme (EM) and
Acute
Generalized
Exanthematous
Pustulosis
(AGEP) have been reported. In most cases,
these could be explained by the severity of the
underlying disease or concomitant administra-
tion of another drug. In the early stages of such
severe skin reactions, initially only nonspecific
flu-like symptoms appear, e.g. fever, arthralgia,
runny nose, cough, and sore throat. If skin or
mucous
membrane
damage
occurs,
s